Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2005-04-26
2005-04-26
Ketter, James (Department: 1636)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C435S320100, C435S458000, C536S023100, C536S024500
Reexamination Certificate
active
06884430
ABSTRACT:
The invention concerns a composition containing stabilized particles of cationic transfection agents
ucleic acid complexes characterized in that it includes besides said transfection agent and nucleic acid at least a non-ionic surfactant in sufficient amount for preventing the aggregation of the particles in course of time. In a preferred embodiment, the surfactant is a polyoxyalkylene or a derivative thereof.
REFERENCES:
patent: 5789244 (1998-08-01), Heidrun et al.
patent: 6086913 (2000-07-01), Tam et al.
patent: 6534484 (2003-03-01), Wheeler et al.
patent: WO 9604932 (1996-02-01), None
patent: WO 9630051 (1996-10-01), None
patent: WO 9640964 (1996-12-01), None
patent: WO 9711682 (1997-04-01), None
Liu et al., New Cationic Lipid Formulations for Gene Transfer, Pharmaceutical Research, vol. 13(12): 1856-60 (1996).
Hara et al., Emulsion formulations as a vector for gene delivery in vitro and in vivo, Advanced Drug Delivery Reviews, vol. 24:265-71 (1997).
Crouzet Joël
Pitard Bruno
Aventis Pharma S.A.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Ketter James
LandOfFree
Formulation of stabilized cationic transfection agent(s)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation of stabilized cationic transfection agent(s)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation of stabilized cationic transfection agent(s)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3399933